Literature DB >> 20216977

Synthetic derivatives of genistein, their properties and possible applications.

Aleksandra Rusin1, Zdzisław Krawczyk, Grzegorz Grynkiewicz, Agnieszka Gogler, Jadwiga Zawisza-Puchałka, Wiesław Szeja.   

Abstract

Genistein, the principal isoflavone constituent of soybean, attracts much attention as a natural molecule with significant affinity towards targets of potential medicinal interest, but also as a food supplement or prospective chemopreventive agent. Since its physicochemical properties are considered suboptimal for drug development, much effort has been invested in designing its analogs and conjugates in hope to obtain compounds with improved efficacy and selectivity. The aim of this article is to summarize current knowledge about the properties of synthetic genistein derivatives and to discuss possible clinical application of selected novel compounds. Some basic information concerning chemical reactivity of genistein, relevant to the synthesis of its derivatives, is also presented.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20216977

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  18 in total

1.  Antagonism of human formyl peptide receptor 1 (FPR1) by chromones and related isoflavones.

Authors:  Igor A Schepetkin; Liliya N Kirpotina; Andrei I Khlebnikov; Ni Cheng; Richard D Ye; Mark T Quinn
Journal:  Biochem Pharmacol       Date:  2014-10-17       Impact factor: 5.858

2.  Chemoprevention against hepatocellular carcinoma.

Authors:  Jun-Ichi Okano; Yuki Fujise; Ryo Abe; Ryu Imamoto; Yoshikazu Murawaki
Journal:  Clin J Gastroenterol       Date:  2011-06-04

3.  Identification of cell surface molecules involved in dystroglycan-independent Lassa virus cell entry.

Authors:  Masayuki Shimojima; Ute Ströher; Hideki Ebihara; Heinz Feldmann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

Review 4.  Phytochemicals for the Management of Melanoma.

Authors:  Harish Chandra Pal; Katherine Marchiony Hunt; Ariana Diamond; Craig A Elmets; Farrukh Afaq
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

5.  Design, synthesis, and evaluation of the antiproliferative activity of hydantoin-derived antiandrogen-genistein conjugates.

Authors:  Alex George; Idris Raji; Bekir Cinar; Omer Kucuk; Adegboyega K Oyelere
Journal:  Bioorg Med Chem       Date:  2018-02-16       Impact factor: 3.641

6.  Distinct signal transduction pathways downstream of the (P)RR revealed by microarray and ChIP-chip analyses.

Authors:  Daniela Zaade; Jennifer Schmitz; Eileen Benke; Sabrina Klare; Kerstin Seidel; Sebastian Kirsch; Petra Goldin-Lang; Frank S Zollmann; Thomas Unger; Heiko Funke-Kaiser
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

7.  A kinase inhibitor screen reveals protein kinase C-dependent endocytic recycling of ErbB2 in breast cancer cells.

Authors:  Tameka A Bailey; Haitao Luan; Eric Tom; Timothy Alan Bielecki; Bhopal Mohapatra; Gulzar Ahmad; Manju George; David L Kelly; Amarnath Natarajan; Srikumar M Raja; Vimla Band; Hamid Band
Journal:  J Biol Chem       Date:  2014-09-15       Impact factor: 5.157

8.  Development of non-natural flavanones as antimicrobial agents.

Authors:  Zachary L Fowler; Karan Shah; John C Panepinto; Amy Jacobs; Mattheos A G Koffas
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

9.  Eudragit nanoparticles containing genistein: formulation, development, and bioavailability assessment.

Authors:  Jingling Tang; Na Xu; Hongyu Ji; Hongmei Liu; Zhiyong Wang; Linhua Wu
Journal:  Int J Nanomedicine       Date:  2011-10-19

10.  Synthetic genistein derivatives as modulators of glycosaminoglycan storage.

Authors:  Anna Kloska; Magdalena Narajczyk; Joanna Jakóbkiewicz-Banecka; Grzegorz Grynkiewicz; Wiesław Szeja; Magdalena Gabig-Cimińska; Grzegorz Węgrzyn
Journal:  J Transl Med       Date:  2012-07-30       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.